Centre hospitalier universitaire de Québec


Standort der Organisation:
Quebec City, Kanada

Publikationen in Kooperation mit FAU-Wissenschaftlerinnen und Wissenschaftlern

Genant, H.K., Engelke, K., Bolognese, M.A., Mautalen, C., Brown, J.P., Recknor, C.,... Libanati, C. (2017). Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass. Journal of Bone and Mineral Research, 32(1), 181-187. https://dx.doi.org/10.1002/jbmr.2932
Keaveny, T.M., Crittenden, D.B., Bolognese, M.A., Genant, H.K., Engelke, K., Oliveri, B.,... Libanati, C. (2017). Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass. Journal of Bone and Mineral Research, 32(9), 1956-1962. https://dx.doi.org/10.1002/jbmr.3176
Langdahl, B.L., Libanati, C., Crittenden, D.B., Bolognese, M.A., Brown, J.P., Daizadeh, N.S.,... Grauer, A. (2017). Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial. Lancet, 390(10102), 1585-1594. https://dx.doi.org/10.1016/S0140-6736(17)31613-6
Wyszynski, A., Hong, C.-C., Lam, K., Michailidou, K., Lytle, C., Yao, S.,... Cole, M.D. (2016). An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. Human Molecular Genetics, 25(17), 3863-3876. https://dx.doi.org/10.1093/hmg/ddw223
Zhang, B., Shu, X.-O., Delahanty, R.J., Zeng, C., Michailidou, K., Bolla, M.K.,... Zheng, W. (2015). Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization. Journal of the National Cancer Institute, 107(11). https://dx.doi.org/10.1093/jnci/djv219
Kabisch, M., Bermejo, J.L., Duennebier, T., Ying, S., Michailidou, K., Bolla, M.K.,... Hamann, U. (2015). Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer. Carcinogenesis, 36(2), 256-71. https://dx.doi.org/10.1093/carcin/bgu326
Stone, J., Thompson, D.J., Silva, I.D.S., Scott, C., Tamimi, R.M., Lindstrom, S.,... Vachon, C.M. (2015). Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures. Cancer Research, 75(12), 2457-67. https://dx.doi.org/10.1158/0008-5472.CAN-14-2012
Milne, R.L., Burwinkel, B., Michailidou, K., Arias-Perez, J.-I., Pilar Zamora, M., Menendez-Rodriguez, P.,... Easton, D.F. (2014). Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium. Human Molecular Genetics, 23(22), 6096-111. https://dx.doi.org/10.1093/hmg/ddu311
Agarwal, D., Pineda, S., Michailidou, K., Herranz, J., Pita, G., Moreno, L.T.,... Milne, R.L. (2014). FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium. British Journal of Cancer, 110(4), 1088-100. https://dx.doi.org/10.1038/bjc.2013.769
Sawyer, E., Roylance, R., Petridis, C., Brook, M.N., Nowinski, S., Papouli, E.,... Garcia-Closas, M. (2014). Genetic predisposition to in situ and invasive lobular carcinoma of the breast. Plos Genetics, 10(4), e1004285. https://dx.doi.org/10.1371/journal.pgen.1004285
Johnson, N., Dudbridge, F., Orr, N., Gibson, L., Jones, M.E., Schoemaker, M.J.,... Fletcher, O. (2014). Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study. Breast Cancer Research, 16(3), R51. https://dx.doi.org/10.1186/bcr3662
Purrington, K.S., Slettedahl, S., Bolla, M.K., Michailidou, K., Czene, K., Nevanlinna, H.,... Couch, F.J. (2014). Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade. Human Molecular Genetics, 23(22), 6034-46. https://dx.doi.org/10.1093/hmg/ddu300
Khan, S., Greco, D., Michailidou, K., Milne, R.L., Muranen, T.A., Heikkinen, T.,... Nevanlinna, H. (2014). MicroRNA Related Polymorphisms and Breast Cancer Risk. PLoS ONE, 9(11), e109973. https://dx.doi.org/10.1371/journal.pone.0109973

Zuletzt aktualisiert 2017-15-02 um 08:41